Provided by Tiger Trade Technology Pte. Ltd.

Biogen

215.43
+4.702.23%
Post-market: 215.430.00000.00%19:30 EDT
Volume:936.62K
Turnover:201.52M
Market Cap:31.81B
PE:38.26
High:216.70
Open:209.92
Low:208.93
Close:210.73
52wk High:225.80
52wk Low:135.39
Shares:147.64M
Float Shares:147.31M
Volume Ratio:1.30
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.69
PE(LYR):24.51

Loading ...

FDA Approves Leqembi Iqlik® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease

THOMSON REUTERS
·
Jul 14

Biogen Inc. Stock Rallies 5.0%, Outperforms Peers

Dow Jones
·
Jul 14

Movement Alert|Biogen Rises 5.26% in Regular Trading, FDA Approves Leqembi Subcutaneous Injection New Initiation Regimen

Market Focus
·
Jul 14

Early subQ approval should help Biogen regain market share, says RBC

TIPRANKS
·
Jul 14

Biogen Rises After FDA Clears At-home Use of Alzheimer's Drug

Reuters
·
Jul 14

Shares of Biogen up 5% After US FDA Approves Subcutaneous Starting Dose for Alzheimer's Drug Leqembi

THOMSON REUTERS
·
Jul 14

FDA: Approves New Starting Dosage Regimen for Leqembi Subcutaneous Formulation for Alzheimer’s Disease Treatment

THOMSON REUTERS
·
Jul 14

Dow Jones Top Company Headlines at 11 am ET: Meta Lifts Cost of Louisiana Data Center to $50 Billion | Intel ...

Dow Jones
·
Jul 13

BMO Capital Sticks to Its Hold Rating for Biogen (BIIB)

TIPRANKS
·
Jul 13

Biogen Stock is Upgraded to Buy Ahead of Key Alzheimer's Drug Study Details

Dow Jones
·
Jul 13

Wedbush Raises Price Target on Biogen to $201 From $196, Keeps Neutral Rating

MT Newswires Live
·
Jul 13

Biogen : Truist Securities Raises to Buy from Hold; Raises Target Price to $235 from $190

THOMSON REUTERS
·
Jul 13

This Biogen Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

Benzinga
·
Jul 13

Biogen Raised to Buy from Hold by Truist Securities

Dow Jones
·
Jul 13

Biogen upgraded to Buy from Hold at Truist

TIPRANKS
·
Jul 13

Biogen, Eisai Report Subcutaneous Leqembi Matches IV Formulation in Early Alzheimer's Study

MT Newswires Live
·
Jul 13

Can Biogen Convince Skeptics That Cutting a Rogue Protein Slows Alzheimer's?

Dow Jones
·
Jul 13

Biogen, Eisai announce new data on efficacy, safety of LEQEMBI SC-AI

TIPRANKS
·
Jul 12

Biopharma Dealmaking on Way to Record Year, Says HSBC

Reuters
·
Jul 10

Range Impact Names Vin Ferrara Vice President of Real Estate

Reuters
·
Jul 09